NEXT Financial Group, Inc - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,0000.0%890.0%0.00%
Q2 2021$1,0000.0%890.0%0.00%
Q1 2021$1,0000.0%890.0%0.00%
Q4 2020$1,00089
+50.8%
0.00%
Q4 2019$0
-100.0%
590.0%0.00%
Q3 2019$1,0000.0%590.0%0.00%
Q2 2019$1,0000.0%590.0%0.00%
Q1 2019$1,0000.0%590.0%0.00%
Q4 2018$1,0000.0%590.0%0.00%
Q3 2018$1,00059
+18.0%
0.00%
Q4 2016$0500.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders